Home
Bayer Group
Overview
The Bayer Group
At Home Throughout The World
Mission
Chairman’s Letter
Executive Council
Report of the Supervisory Board
Global Commitment to Sustainability
Governance Bodies
Supervisory Board
Board of Management
Organization Chart
Key Data
Key Data
Five-Year Financial Summary
Management Report
Overview of Sales, Earnings and Financial Position
Business and Operating Environment
Corporate Structure
Economic Environment
Procurement and Production
Products, Distribution and Markets
Performance by Subgroup, Segment and Region
HealthCare
CropScience
MaterialScience
Performance by Region
Business Development in the Emerging Markets
Earnings; Asset and Financial Position
Earnings Performance of the Bayer Group
Calculation of EBIT(DA) Before Special Items
Core Earnings Per Share
Value Management
Liquidity and Capital Expenditures of the Bayer Group
Asset and Capital Structure of the Bayer Group
Earnings; Asset and Financial Position of Bayer AG
Earnings Performance of Bayer AG
Asset and Financial Position of Bayer AG
Takeover-Relevant Information
Corporate-Governance-Report
Declaration on Corporate Governance
Compensation Report
Research and Development
Sustainability
Sustainability Strategy
Employees
Environment, Climate Protection and Safety
Social Commitment
Events After the Reporting Period
Future Perspectives
Opportunity and Risk Report
Strategy
Economic Outlook
Sales and Earnings Forecast
Financial Statements
Income Statements
Comprehensive Income
Financial Position
Cash Flows
Changes in Equity
Notes to the Consolidated Financial Statements of the Bayer Group
Key data by segment and region
General information
Effects of new accounting pronouncements
Basic principles, methods and critical accounting estimates
Segment reporting
Scope of consolidation; subsidiaries and affiliates
Changes in the scope of consolidation
Business combinations and other acquisitions
Divestitures and assets held for sale
Notes to the Income Statements
Notes to the Statements of Financial Position
Notes to the Statements of Cash Flows
Other Information
Responsibility Statement
Independent Auditor’s Report
Bayer Stock
Magazine
Overview
Research is key
Active partnerships
Opening up new markets
Highlights 2011
Services
Services Overview
Download Center
Glossary
Chairman’s Letter
2011: Bayer achieves financial and innovation targets
“Dear Stockholders: It is a great pleasure to present to you Bayer’s Annual Report for 2011,
a very successful year for our company.”
» more
Magazine
Building on our strengths
How can we improve people’s quality of life? Read what our three subgroups are doing to drive innovation, strengthen marketing and expand our market presence in our multimedia magazine.
» more
Bayer Group
About Bayer Group
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.
» more
Key Data
Bayer: sales and EBIT at record levels
On a currency- and portfolio-adjusted (Fx & portfolio adj.) basis, we raised Group sales by 5.5% (reported: +4.1%) to €36.5 billion.
» more
Management Report
Overview of Sales, Earnings and Financial Position
Bayer had a very successful year in 2011, both strategically and operationally. Read more about the overview of Sales, Earnings and Financial Position.
» more
Bayer Stock
Bayer Stock performance above market but below Healthcare Index
The performance of Bayer stock – including the dividend of €1.50 per share paid in May 2011 – came to minus 8 percent for the year.
» more
Bayer Group
Bayer Global
Bayer HealthCare
Bayer CropScience
Bayer MaterialScience
Bayer Business Services
Bayer Technology Services
Currenta
Special Interest
Investor Relations
Press
Jobs and Career
Foundations
Sports
Culture
Social Media
Print page
Search
Search
Index from A to Z
Please select
Accounting standards
Acquisition accounting
Acquisitions
Annual Stockholders’ Meeting
Asset position (Bayer AG)
Asset structure (Bayer Group)
Audit Committee
Audit fees
Auditor
Auditor’s report
Bayer Business Services
Bayer stock data
Bayer stock programs
Bayer Technology Services
Board of Management
Bonds
Business strategy
Capital expenditures
Capital structure
Changes in equity
Commodity price risks
Companies consolidated
Compensation of the Board of Management
Compensation of the Supervisory Board
Compliance Officers
Consolidated financial statements
Consolidated statements of cash flows
Consolidated statements of comprehensive income
Consolidation
Contact
Contingent liabilities
Core earnings per share
Corporate citizen
Corporate compliance
Corporate governance
Corporate Governance Code
Corporate structure
Critical accounting estimates
CropScience
Currency risk
Currenta
Derivatives
Distribution
Dividend
Earnings per share
Earnings performance (Bayer Group)
Economic outlook
Employees
Environmental protection
Events after the end of the reporting period
Exchange rate risk
Exchange rates
Financial calendar
Financial instruments
Financial liabilities
Financial position (Bayer AG)
Financial risks
Financial strategy
Five-year financial summary
Future perspectives
Goodwill
Governance bodies
Gross cash flow
Group structure
HealthCare
Hedge accounting
Highlights
Human Resources Committee
Impairment losses
Impairment testing
Income from investments in affiliated companies
Income losses attributable to non-controlling interest
Income statements (Bayer AG)
Income statements (Bayer Group)
Income taxes
Intangible assets
Interest expense
Interest-rate risk
Inventories
Investor relations
Key data by segment and region
Key data by subgroup
Key performance indicators
Leasing
Legal risks
Management report (Combined Management Report of Bayer AG and the Bayer Group)
Markets
MaterialScience
Net cash flow
Net debt
Net income
Nominations Committee
Non-operating result
Notes to the consolidated financial statements
Opportunities
Organization chart
Other financial assets
Other financial committments
Other non-operating income and expense
Other operating expenses
Other operating income
Other receivables
Personnel expenses
Presidial Committee
Procurement
Procurement market risk
Production
Property, plant and equipment
Provisions
Provisions for pensions and other post-employment benefits
R&D expenses
Recognition and measurement principles
Regions
Research and development
Responsibility statement
Responsible Care
Restructuring charges
Risk management
Risk Report
Salaries
Sales
Scope of consolidation
Segment reporting
Segments
Statements of financial position
Strategy
Supervisory Board
Sustainability
Sustainable development
Sustainable investment
Taxes
Trade accounts payable
Trade accounts receivable
UNEP
Value management
Download Center
Complete
Report
(
PDF
8596 KB)
Add to Download Center
Your Selection:
Video
Financial Data 2011: Sales and EBIT at Record Levels
(8:05 min.)
Services
Order print version
Event Reminder
Press Newsletter
Financial Reports Newsletter
SMS Service
Full Year 2011 Results
Investor Conference Call
Annual Stockholders' Meeting 2012
Info
Notes on our information package and all services
» Bayer Group
Deutsch
Sitemap
Search
RSS
Contact
Textversion
×